Results 11 to 20 of about 27,803 (242)

New antagonist agents of neuropeptide y receptors [PDF]

open access: yesQuímica Nova, 2000
In the CNS, NPY has been implicated in obesity and feeding, endocrine function and metabolism. Potent and selective rNPY antagonists will be able to probe the merits of this approach for the treatment of obesity.
Ignacio Aldana   +8 more
doaj   +6 more sources

Neuropeptide Y receptors: How to get subtype selectivity [PDF]

open access: yesFrontiers in Endocrinology, 2013
The neuropeptide Y system is a multireceptor/multiligand system consisting of four receptors in humans (hY1, hY2, hY4, hY5) and three agonists (NPY, PYY, PP) that activate these receptors with different potency.
Xavier ePedragosa Badia   +2 more
doaj   +4 more sources

Evolution of neuropeptide Y/RFamide-like receptors in nematodes

open access: yesHeliyon
The Neuropeptide Y/RFamide-like receptors belong to the Rhodopsin-like G protein-coupled receptors G protein-coupled receptors (GPCRs) and are involved in functions such as locomotion, feeding and reproduction.
Franziska Reinhardt   +3 more
doaj   +4 more sources

Neuropeptide Y receptor in the rat brain [PDF]

open access: yesEuropean Journal of Biochemistry, 1984
The specific binding of the chloramine-T iodinated neuropeptide Y (125I-NPY) to membranes from rat cerebral cortex was investigated using equilibrium binding and kinetic methods. The equilibrium binding of 125I-NPY at 37 degrees C was characterized by a Kd value of 0.38 nM. The receptor densities in the cerebral cortex, hypothalamus and cerebellum were
Viktor Mutt   +3 more
openaire   +3 more sources

Characterization of vascular neuropeptide Y receptors [PDF]

open access: yesBritish Journal of Pharmacology, 1992
In the present study we compared neuropeptide Y (NPY) and NPY‐related analogues for their ability to activate or bind to vascular NPY receptors in four experimental set‐ups. Previous results have suggested the existence of different receptor subtypes, Y1 receptors requiring full‐length NPY (1–36) or [Pro34]‐NPY, and Y2 receptors recognizing also N ...
Rolf Håkanson   +5 more
openaire   +3 more sources

Ligands of the neuropeptide Y Y2 receptor [PDF]

open access: yesBioorganic & Medicinal Chemistry Letters, 2014
AbstractReview: 64 refs.
Gopi Kumar Mittapalli, Edward Roberts
openaire   +4 more sources

Synthesis of receptor antagonists of neuropeptide Y. [PDF]

open access: yesProceedings of the National Academy of Sciences, 1992
We report the synthesis of receptor antagonists of neuropeptide Y (NPY) by a strategy based on synthesis of mixtures of analogs and the subsequent isolation and identification of receptor antagonists from these mixtures. After screening a series of mixtures of NPY analogs by using an NPY antagonist assay, two potent receptor antagonists, designated PYX-
Meikyo Shimizu   +2 more
openaire   +3 more sources

NPY1R (neuropeptide Y receptor Y1) [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2011
Review on NPY1R (neuropeptide Y receptor Y1), with data on DNA, on the protein encoded, and where the gene is implicated.
M. Ruscica   +3 more
openaire   +4 more sources

Y1 and Y2 receptors for neuropeptide Y [PDF]

open access: yesFEBS Letters, 1989
By using monoiodinated radioligands of both intact neuropeptide Y (NPY) and of a long C‐terminal fragment, NPY13–36, two subtypes of binding sites, which differ in affinity and specificity, have been characterized. The Y1 type of binding site, characterized on a human neuroblastoma cell line, MC‐IXC, and a rat pheochromocytoma cell line, PC‐12, binds ...
Thue W. Schwartz   +2 more
openaire   +3 more sources

A companion to the preclinical common data elements and case report forms for neuropathology studies in epilepsy research. A report of the TASK3 WG2 Neuropathology Working Group of the ILAE/AES Joint Translational Task Force

open access: yesEpilepsia Open, EarlyView., 2022
Abstract The International League Against Epilepsy/American Epilepsy Society (ILAE/AES) Joint Translational Task Force initiated the TASK3 working group to create common data elements (CDEs) for various aspects of preclinical epilepsy research studies, which could help improve the standardization of experimental designs.
Eleonora Aronica   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy